Tsudome, R. (2025) “Anti-Oxidative Effect of Dapagliflozin, a Selective Sodium Glucose Transporter-2 Inhibitor, for Cardio-Renal Protection in Patients With Heart Failure With Reduced Ejection Fraction”, Cardiology Research, 16(6), pp. 489–498. doi:10.14740/cr2109.